94 related articles for article (PubMed ID: 15644616)
1. Tissue retention and adverse reaction after intravenous injection of hematoporphyrin derivatives in dogs.
Okamoto Y; Yonemura D; Miyatake K; Hashimoto Y; Hirano T; Sakata I; Minami S
J Vet Med Sci; 2004 Dec; 66(12):1599-601. PubMed ID: 15644616
[TBL] [Abstract][Full Text] [Related]
2. Distribution of hematoporphyrin derivative in canine glioma following intraneoplastic and intraperitoneal injection.
Steichen JD; Dashner K; Martuza RL
J Neurosurg; 1986 Sep; 65(3):364-9. PubMed ID: 2942650
[TBL] [Abstract][Full Text] [Related]
3. Penetration of hematoporphyrin derivative into rat brain and intracerebral 9L glioma tissue.
Boisvert DP; McKean JD; Tulip J; Cummins J; Cheng MK
J Neurooncol; 1985; 3(2):113-8. PubMed ID: 3162004
[TBL] [Abstract][Full Text] [Related]
4. Distribution, retention, and phototoxicity of hematoporphyrin derivative in a rat glioma. Intraneoplastic versus intraperitoneal injection.
Kostron H; Bellnier DA; Lin CW; Swartz MR; Martuza RL
J Neurosurg; 1986 May; 64(5):768-74. PubMed ID: 2939204
[TBL] [Abstract][Full Text] [Related]
5. Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse.
Bugelski PJ; Porter CW; Dougherty TJ
Cancer Res; 1981 Nov; 41(11 Pt 1):4606-12. PubMed ID: 7306978
[TBL] [Abstract][Full Text] [Related]
6. Effect of route of administration on the selectivity of hematoporphyrin derivative for tumor tissue.
Elmer EB; Wood WC; Cohen AM; Bamberg M
J Surg Oncol; 1987 Feb; 34(2):113-9. PubMed ID: 2949116
[TBL] [Abstract][Full Text] [Related]
7. [Effect of ascorbate on the permeation and photosensitizing activity of hematoporphyrin derivative (HPD) in tumor].
Chen Y; Li C; Liu Y
Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):350-2. PubMed ID: 10920914
[TBL] [Abstract][Full Text] [Related]
8. Distribution of hematoporphyrin derivative in normal and malignant tissue.
Hara N; Ichinose Y; Motohiro A; Ohta M; Yagawa K
Jpn J Exp Med; 1988 Jun; 58(3):139-43. PubMed ID: 2972857
[TBL] [Abstract][Full Text] [Related]
9. A photodynamic therapy combined with topical 5-aminolevulinic acid and systemic hematoporphyrin derivative is more efficient but less phototoxic for cancer.
Wang Y; Lin Y; Zhang HG; Zhu J
J Cancer Res Clin Oncol; 2016 Apr; 142(4):813-21. PubMed ID: 26581214
[TBL] [Abstract][Full Text] [Related]
10. Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue.
Gomer CJ; Dougherty TJ
Cancer Res; 1979 Jan; 39(1):146-51. PubMed ID: 761185
[TBL] [Abstract][Full Text] [Related]
11. Components of hematoporphyrin derivatives and their tumor-localizing capacity.
Kessel D
Cancer Res; 1982 May; 42(5):1703-6. PubMed ID: 7066890
[TBL] [Abstract][Full Text] [Related]
12. Skin photosensitivity: duration and intensity following intravenous hematoporphyrin derivates, HpD and DHE.
Razum N; Balchum OJ; Profio AE; Carstens F
Photochem Photobiol; 1987 Nov; 46(5):925-8. PubMed ID: 2964669
[No Abstract] [Full Text] [Related]
13. Fluorescing cells in sputum after parenteral HpD.
Patel KB; Qin YN; Balchum OJ; Doiron DR
Prog Clin Biol Res; 1984; 170():521-30. PubMed ID: 6241694
[TBL] [Abstract][Full Text] [Related]
14. [Selective hematoporphyrin derivative (HMD) application in arterial vessels using a porous balloon catheter results in equivalent levels as compared to high-dose systemic administration].
Gonschior P; Erdemci A; Gerheuser F; Gonschior GM; Mack B; Kolbe T; Goetz AE; Höfling B
Z Kardiol; 1991 Dec; 80(12):738-45. PubMed ID: 1837968
[TBL] [Abstract][Full Text] [Related]
15. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
Wong Kee Song LM; Wang KK; Zinsmeister AR
Cancer; 1998 Jan; 82(2):421-7. PubMed ID: 9445202
[TBL] [Abstract][Full Text] [Related]
16. [Time resolved laser fluorescence microscopy of hematoporphyrin derivative in vivo].
Feyh J; Goetz A; Schneckenburger H; Müller W; Kastenbauer E
Laryngorhinootologie; 1991 Jan; 70(1):41-4. PubMed ID: 1827265
[TBL] [Abstract][Full Text] [Related]
17. Uptake and retention of hematoporphyrin derivative in an in vivo/in vitro model of cerebral glioma.
Kaye AH; Morstyn G; Ashcroft RG
Neurosurgery; 1985 Dec; 17(6):883-90. PubMed ID: 2934641
[TBL] [Abstract][Full Text] [Related]
18. Nature of the tumor-localizing components of hematoporphyrin derivative.
Scourides PA; Böhmer RM; Kaye AH; Morstyn G
Cancer Res; 1987 Jul; 47(13):3439-45. PubMed ID: 3581080
[TBL] [Abstract][Full Text] [Related]
19. Quantum yield of singlet oxygen production by monomeric and aggregated forms of hematoporphyrin derivative.
Tanielian C; Schweitzer C; Mechin R; Wolff C
Free Radic Biol Med; 2001 Jan; 30(2):208-12. PubMed ID: 11163538
[TBL] [Abstract][Full Text] [Related]
20. Treatment of mouse carcinomas with intratumoral injections of hematoporphyrin derivative and red light.
Moseng D; Volden G; Midelfart K; Kavli G; Christensen T; Moan J
Photodermatol; 1985 Apr; 2(2):107-10. PubMed ID: 4034416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
